Learn more
Log in
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Stage
Employees
Links
Niels C. Riedemann
7 members
5 members
4 members
3 members
AxoSim
1 follower
KEW
MBCOM IT-Systemhaus GmbH
GapFish
Wattkraft
Discover companies